Skip to content

Sharp offer well-established QP services, helping to streamline your product’s journey to trial and market in the EU and giving you and your customers confidence that your products have been manufactured to the very highest standards.

QP Release Services

Once a satisfactory audit is complete, your Sharp QP will issue a declaration that you can use to submit your Clinical Trial Authorisation (CTA). We can then work with you to manage the storage and distribution of your clinical trial supplies to your testing sites.

The Role of a (QP) Qualified Person

It is a requirement within the EU that all investigational and medicinal products manufactured or imported by organisations holding a MA IMP, have a QP to approve and release each batch of IMP for usage in clinical trials. QPs have gained personal knowledge of the quality systems used at the manufacturing site, usually through an EU Good Manufacturing Practice Audit.

QPs are assigned projects according to their specialist expertise and have personal and legal responsibility as defined by the EU Clinical Trial Directive (2001/20/EC).

Talk to our expert team today about your QP release needs.

Related Resources

Are you still managing your drug supply manually? Find out how you can save time with #Clinventory - our self-service, automated Inventory Management System.

Reach out to arrange a short demo and discover the power of Clinventory: https://lnkd.in/eKxDNDdH

The role of the EU Qualified person

Dr Ria Rhemrev from @Sharp_Services will take Manufacturing Chemist Live delegates through the role and its impacts on the end delivery in the supply chain.

Book now: https://bit.ly/3y2qQeZ

#ManChemLive

Here's a chance to view a recorded webinar from @Sharp_Services on the internal & external forces impacting the scaling of #clinical and #commercial drug and how to alleviate these issues.
https://buff.ly/30cPZVK